EU begins discussions with Japan over MRA (mutual recognition agreement):
This article was originally published in Clinica
Executive Summary
The medical devices units within the European Commission is about to start discussions with Japan concerning the drafting of a joint implementation plan for a mutual recognition agreement (MRA) between the two markets. Talks will be led by the EC's Directorate General Trade and will cover a variety of industrial sectors. They will be held via video conference between April 12-14. The devices unit has prepared well for this opportunity, but is understood to be open to suggestions from the Japanese. The intention is for timeframes to be agreed during the talks, as well as dates for future bilateral meetings.
You may also be interested in...
US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments
FDA’s efforts to tackle misinformation may face fewer legal obstacles moving forward, following oral arguments at the Supreme Court on a case that could have broad ramifications for how the government communicates public health information.
The Dog That Didn’t Bark: ODAC Gives Nod To Three Products Despite Negative FDA Reviews
Oncologic Drugs Advisory Committee was swayed by views of its disease area experts in favorably reporting out Geron’s imetelstat for myelodysplastic syndromes and supplemental applications for the CAR-T products Carvykti and Abecma in earlier lines of multiple myeloma.
Demi Moore’s Wonderbelly Antacid Investment Lands Supporting Role In Her Promotional Posts
Wonderbelly Antacids “free from” ad claims work but failing to disclose Demi Moore is an investor in her promotions doesn’t, NAD says. Dakota Nutrition fails again on NAD’s test of its testing for elderberry in its supplements.